LYMNUTRO

Serial Number 90642264
606

Registration Progress

Application Filed
Apr 13, 2021
Under Examination
Nov 2, 2021
Approved for Publication
Sep 7, 2021
Published for Opposition
Sep 7, 2021
Registered

Basic Information

Serial Number
90642264
Filing Date
April 13, 2021
Published for Opposition
September 7, 2021
Abandonment Date
December 9, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 9, 2024
Classes
005

Rights Holder

X4 Pharmaceuticals, Inc.

03
Address
61 North Beacon Street, 4th Floor
Boston, MA 02134

Ownership History

X4 Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

X4 Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Glenn A. Gundersen

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description
Dec 9, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 9, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 23, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 23, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 23, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 30, 2024 EXT5 S SOU EXTENSION 5 FILED
Apr 30, 2024 EX5G S SOU EXTENSION 5 GRANTED
Oct 31, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2023 EX4G S SOU EXTENSION 4 GRANTED
Oct 28, 2023 EXT4 S SOU EXTENSION 4 FILED
Oct 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
May 2, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2023 EX3G S SOU EXTENSION 3 GRANTED
Apr 30, 2023 EXT3 S SOU EXTENSION 3 FILED
Apr 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2022 EX2G S SOU EXTENSION 2 GRANTED
Oct 31, 2022 EXT2 S SOU EXTENSION 2 FILED
Oct 31, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 31, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 31, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 31, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 3, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2022 EX1G S SOU EXTENSION 1 GRANTED
Apr 29, 2022 EXT1 S SOU EXTENSION 1 FILED
Apr 29, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 2, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 7, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 PUBO A PUBLISHED FOR OPPOSITION
Aug 18, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 5, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2021 DOCK D ASSIGNED TO EXAMINER
Jul 20, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for the treatment of immunodeficiencies; Pharmaceutical preparations for the treatment of neutropenia; Pharmaceutical preparations for the treatment of Waldenström's macroglobulinemia; Pharmaceutical preparations for the treatment of cancer

Classification

International Classes
005